At what enterprise value was GROUPE RESONANCE IMAGERIE acquired in 2022?

During the acquisition of GROUPE RESONANCE IMAGERIE by ANDERA PARTNERS in 2022, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of GROUPE RESONANCE IMAGERIE when it was acquired by ANDERA PARTNERS?

The estimated EV/EBITDA multiple for GROUPE RESONANCE IMAGERIE is in the range of 15x - 25x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.4x. Join our community for free to access full valuation data and industry trends.

What was the revenue of GROUPE RESONANCE IMAGERIE at the time of the deal?

The revenue of GROUPE RESONANCE IMAGERIE at the time of the deal is estimated to be in the range of 25M - 50M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of GROUPE RESONANCE IMAGERIE during the acquisition?

GROUPE RESONANCE IMAGERIE's EBITDA is estimated to be in the range of 5M - 25M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the GROUPE RESONANCE IMAGERIE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the GROUPE RESONANCE IMAGERIE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.anderapartners.com/fr/andera-midcap-participe-au-financement-du-groupe-resonance-imagerie/

← DATABASE

Home Database Healthcare & PharmaGROUPE RESONANCE IMAGERIE

07/2022

GROUPE RESONANCE IMAGERIE acquired by ANDERA PARTNERS

FRANCE Health Providers / Outpatient Care / Radiology EV 100M - 350M EUR

Context

R�sonance Imagerie, a prominent French medical imaging group, has secured a major financing package from Andera MidCap, Ardian Private Debt, and Five Arrows Debt Partners. Established in 2011, the group currently operates a network of 15 centers across Paris, �le-de-France, and the Centre-Val-de-Loire region, managing 23 high-tech units including MRIs and scanners.

GROUPE RESONANCE IMAGERIE, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Groupe Résonance Imagerie (founded in 2011) is a leading independent outpatient radiology and medical imaging network in France. The group operates a specialized clinical model combining a high volume of conventional radiology with advanced cross-sectional heavy imaging expertise. Its core value proposition focuses on providing tier-one diagnostic excellence through cutting-edge modalities (MRI, CT scans, mammography) alongside streamlined technical and administrative operational management.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Other operations with GROUPE RESONANCE IMAGERIE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
10/2025	GROUPE RESONANCE IMAGERIE	CIMEP	FRANCE	Health Providers	Groupe Resonance Imagerie, a french medical imaging group supported by Andera Partners for the past three years, is pursuing its geographical consolidation strategy by acquiring the Parisian company Cimep, which brings it 12 centers and nearly EUR20 million in additional revenue. The organization operates as a high-fidelity practitioner-led platform, focusing on the seamless integration of radiology expertise with advanced medical imaging technologies. Rather than focusing solely on basic diagnostics, the firm thrives on a philosophy of technical operational depth, managing a distributed network of centers that provide high-capacity scanning, MRI, and ultrasound services. Its value proposition centers on maintaining a strong medical project led by senior practitioners, ensuring high clinical standards for patients in the Val-de-Marne and Seine-Saint-Denis areas.

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of GROUPE RESONANCE IMAGERIE by ANDERA PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: groupe resonance imagerie

Acquirer: andera partners